GSK-4362620A

N/A

Report date: 2021/12/14 09:47:08

Base Information

Drug NameGSK-4362620A
Drug Alias NameCOVID-19 plant-derived virus-like particles vaccine (Medicago)GSK-4362620A
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulatorsCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedicago IncGsk Vaccines Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesMedicago IncGsk Vaccines Gmbh
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A